XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Deficit (unaudited) - USD ($)
$ in Thousands
Total
Public Offering
Common Stock
Common Stock
Public Offering
Common Stock
Cidal
Additional Paid-in Capital
Additional Paid-in Capital
Public Offering
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Total Athenex, Inc. Stockholders' Equity
Total Athenex, Inc. Stockholders' Equity
Public Offering
Non-Controlling Interests
Beginning balance at Dec. 31, 2020 $ 165,348   $ 95     $ 901,864   $ (713,644) $ (1,134) $ (7,406) $ 179,775   $ (14,427)
Beginning balance, shares at Dec. 31, 2020     95,066,195             (1,672,920)      
Stock-based compensation cost 2,205         2,205         2,205    
Restricted stock expense 29         29         29    
Stock options exercised 852         852         852    
Stock options exercised, shares     119,425                    
Net loss (25,603)             (25,050)     (25,050)   (553)
Other comprehensive income (loss), net of tax 293               293   293    
Ending balance at Mar. 31, 2021 143,124   $ 95     904,950   (738,694) (841) $ (7,406) 158,104   (14,980)
Ending balance, shares at Mar. 31, 2021     95,185,620             (1,672,920)      
Beginning balance at Dec. 31, 2020 165,348   $ 95     901,864   (713,644) (1,134) $ (7,406) 179,775   (14,427)
Beginning balance, shares at Dec. 31, 2020     95,066,195             (1,672,920)      
Net loss (96,954)                        
Ending balance at Sep. 30, 2021 135,879   $ 111     969,315   (809,025) (1,037) $ (7,485) 151,879   (16,000)
Ending balance, shares at Sep. 30, 2021     110,991,959             (1,672,920)      
Beginning balance at Dec. 31, 2020 165,348   $ 95     901,864   (713,644) (1,134) $ (7,406) 179,775   (14,427)
Beginning balance, shares at Dec. 31, 2020     95,066,195             (1,672,920)      
Ending balance at Dec. 31, 2021 34,452   $ 111     972,404   (913,412) (487) $ (7,485) 51,131   (16,679)
Ending balance, shares at Dec. 31, 2021     111,802,968             (1,672,920)      
Beginning balance at Mar. 31, 2021 143,124   $ 95     904,950   (738,694) (841) $ (7,406) 158,104   (14,980)
Beginning balance, shares at Mar. 31, 2021     95,185,620             (1,672,920)      
Sale of common stock, shares     33,373                    
Sale of common stock 133         133         133    
Issuance of common stock in connection with acquisition of Kuur and settlement of transaction incentive liability assumed, shares     15,601,667                    
Issuance of common stock in connection with acquisition of Kuur and settlement of transaction incentive liability assumed 58,428   $ 16     58,412         58,428    
Stock-based compensation cost 2,387         2,387         2,387    
Restricted stock expense 57         57         57    
Stock options exercised 727         727         727    
Stock options exercised, shares     160,000                    
Treasury stock repurchase (79)                 $ (79) (79)    
Net loss (34,615)             (34,274)     (34,274)   (341)
Other comprehensive income (loss), net of tax (282)               (282)   (282)    
Ending balance at Jun. 30, 2021 169,880   $ 111     966,666   (772,968) (1,123) $ (7,485) 185,201   (15,321)
Ending balance, shares at Jun. 30, 2021     110,980,660             (1,672,920)      
Issuance of common stock in connection with acquisition of Kuur and settlement of transaction incentive liability assumed, shares         11,299                
Stock-based compensation cost 2,450         2,450         2,450    
Restricted stock expense 199         199         199    
Net loss (36,736)             (36,057)     (36,057)   (679)
Other comprehensive income (loss), net of tax 86               86   86    
Ending balance at Sep. 30, 2021 135,879   $ 111     969,315   (809,025) (1,037) $ (7,485) 151,879   (16,000)
Ending balance, shares at Sep. 30, 2021     110,991,959             (1,672,920)      
Beginning balance at Dec. 31, 2021 34,452   $ 111     972,404   (913,412) (487) $ (7,485) 51,131   (16,679)
Beginning balance, shares at Dec. 31, 2021     111,802,968             (1,672,920)      
Sale of common stock through ATM shares     1,646,026                    
Sale of common stock through ATM 1,695   $ 2     1,693         1,695    
Stock-based compensation cost 1,623         1,623         1,623    
Restricted stock expense 251         251         251    
Issuance of warrants 148         148         148    
Net loss (17,932)             (17,420)     (17,420)   (512)
Other comprehensive income (loss), net of tax 562               562   562    
Ending balance at Mar. 31, 2022 20,799   $ 113     976,119   (930,832) 75 $ (7,485) 37,990   (17,191)
Ending balance, shares at Mar. 31, 2022     113,448,994             (1,672,920)      
Beginning balance at Dec. 31, 2021 34,452   $ 111     972,404   (913,412) (487) $ (7,485) 51,131   (16,679)
Beginning balance, shares at Dec. 31, 2021     111,802,968             (1,672,920)      
Net loss (70,175)                        
Ending balance at Sep. 30, 2022 7,236   $ 159     1,012,114   (982,658) 2,987 $ (7,757) 24,845   (17,609)
Ending balance, shares at Sep. 30, 2022     159,108,639             (1,698,541)      
Beginning balance at Mar. 31, 2022 20,799   $ 113     976,119   (930,832) 75 $ (7,485) 37,990   (17,191)
Beginning balance, shares at Mar. 31, 2022     113,448,994             (1,672,920)      
Sale of common stock through ATM shares     5,501,866                    
Sale of common stock through ATM 2,780   $ 5     2,775         2,780    
Sale of common stock through ESPP shares     372,963                    
Sale of common stock through ESPP 188   $ 1     187         188    
Stock-based compensation cost 1,358         1,358         1,358    
Restricted stock expense 245         245         245    
Issuance of warrants 135         135         135    
Net loss (32,374)             (32,157)     (32,157)   (217)
Other comprehensive income (loss), net of tax 1,396               1,396   1,396    
Ending balance at Jun. 30, 2022 (5,473)   $ 119     980,819   (962,989) 1,471 $ (7,485) 11,935   (17,408)
Ending balance, shares at Jun. 30, 2022     119,323,823             (1,672,920)      
Sale of common stock, shares       35,333,334                  
Sale of common stock   $ 17,773   $ 35     $ 17,738         $ 17,773  
Sale of common stock through ATM shares     3,957,485                    
Sale of common stock through ATM 1,599   $ 4     1,595         1,599    
Sale of common stock through ESPP shares     359,097                    
Sale of common stock through ESPP 188   $ 1     187         188    
Issuance of pre-funded warrants, net of costs of $155 2,343         2,343         2,343    
Stock-based compensation cost 1,268         1,268         1,268    
Vesting of restricted stock units 141         141         141    
Vesting of restricted stock units, shares     134,900                    
Treasury stock repurchase (272)                 $ (272) (272)    
Treasury stock repurchase, shares                   (25,621)      
Issuance of warrants 8,023         8,023         8,023    
Net loss (19,870)             (19,669)     (19,669)   (201)
Other comprehensive income (loss), net of tax 1,516               1,516   1,516    
Ending balance at Sep. 30, 2022 $ 7,236   $ 159     $ 1,012,114   $ (982,658) $ 2,987 $ (7,757) $ 24,845   $ (17,609)
Ending balance, shares at Sep. 30, 2022     159,108,639             (1,698,541)